title: [Stereotactic radiation therapy for non small cell lung cancer].
abstract: Stereotactic radiation therapy (SRT) is a highly effective treatment for brain metastases from non-small cell lung cancer (NSCLC). Primary lesions of NSCLC may also be controlled by SRT. Between 1994 and 1999, 50 patients with pathologically confirmed T1-2N0 M0 NSCLC were treated with SRT. With a median follow-up period of 36 months, 3-year cause-specific survival was 88%. SRT is a very safe and effective treatment for early stage NSCLC.
authors.affiliation: National Defense Medical College, Tokorozawa, Japan.
authors.forename: Minoru
authors.initials: M
authors.lastname: Uematsu
mesh_terms: D001932:Brain Neoplasms / Q000556:secondary* / Q000601:surgery*; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000556:secondary* / Q000601:surgery*; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000601:surgery*; D016634:Radiosurgery / Q000295:instrumentation / Q000379:methods*; D012189:Retrospective Studies; D013238:Stereotaxic Techniques; D015996:Survival Rate; D013997:Time Factors